This article explores recent advancements in HIV vaccine development, focusing on mosaic vaccines, broadly neutralizing antibodies (bNAbs), and novel vaccine platforms like mRNA and viral vectors. Despite challenges, ongoing clinical trials and innovative approaches offer hope for an effective, accessible HIV vaccine, bringing us closer to ending the epidemic.
Recent Advances in HIV Vaccine Development
